European Journal of Medicinal Chemistry (2020)
Update date:2022-08-17
Topics:
Hilton-Proctor, J. P.
Ilyichova, O.
Jennings, I. G.
Johnstone, R. W.
Mountford, S. J.
Scanlon, M. J.
Shortt, J.
Thompson, P. E.
Zheng, Z.
N-Methylpyrrolidone is one of several chemotypes that have been described as a mimetic of acetyl-lysine in the development of bromodomain inhibitors. In this paper, we describe the synthesis of a 4-phenyl substituted analogue – 1-methyl-4-phenylpyrrolidin-2-one – and the use of aryl substitution reactions as a divergent route for derivatives. Ultimately, this has led to structurally complex, chiral compounds with progressively improved affinity as inhibitors of bromodomain-containing protein 4.
View MoreHebei Tianxiang Biological & Pharmaceutical Co., Ltd
Contact:86-0312-6615158
Address:No 42 fazhan street qingyuan county
Ningbo Inno Pharmchem Co., Ltd.
Contact:86-574-87319282
Address:6F-5,NO.163 RUIQING RD.,NINGBO 315000 CHINA
Laizhou City Laiyu Chemical CO.,Ltd
Contact:+86-535-2719337/2719339
Address:Chenggang road zhuyou laizhou City Shangdong China
Angelisun(Chongqing) Pharmaceutical Co., LTD.
Contact:+86-23-68030926-816
Address:D1-7 Tech & Entrepreneurs Park, Kecheng Road, Erlang Hi-Tech Areas, Chongqing, China
Shaanxi King Stone Enterprise Company Limited
Contact:86-29-88353805,13609285751
Address:.209 Keji Road Hi-Tech industrial Develpment Zone .Xian China
Doi:10.1002/hlca.19680510210
(1968)Doi:10.1021/acs.orglett.9b04050
(2019)Doi:10.1002/kin.20991
(2016)Doi:10.1016/S0040-4039(01)99185-3
(1968)Doi:10.1016/0040-4039(96)00833-7
(1996)Doi:10.1002/hlca.19670500833
(1967)